LXRX Q4 2020 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$704M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$199,000-97.7% YoY

Gross Profit

-$793,000-398.5% margin

Operating Income

-$7M-3747.7% margin

Net Income

-$5M-2761.3% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-97.0%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$204M

Total Liabilities

$47M

Stockholders' Equity

$156M

Cash & Equivalents

$126M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$199,000	$9M	-97.7%
Gross Profit	-$793,000	$8M	-110.0%
Operating Income	-$7M	-$47M	+84.2%
Net Income	-$5M	-$51M	+89.3%